Submit Manuscript    >>    Login | Register

Aims & Scope

Atrial fibrillation is the most common sustained cardiac rhythm disorder, and confers a substantial mortality and morbidity from stroke, thromboembolism, heart failure, and impaired quality of life. With the increasingly elderly population in the developed world, as well as improvements in the management of myocardial infarction and heart failure, the prevalence of atrial fibrillation is increasing, resulting in a major public-health problem. Journal of Atrial Fibrillation (JAFIB) exists to serve the needs of this diverse community, providing a forum for communicating original and innovative research findings that have relevance to understanding the pathophysiology of cardiac rhythm abnormalities and to improving the treatment and survival of patients. JAFIB works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.

Full research papers and short communications are published under the following broad headings:
  • Surgical management
  • Medical treatment of AF
  • Technology and Devices
  • Genetics and Genomics
  • Epidemiology
  • Non-medical Therapies
  • Biological pathways
  • Cell & Molecular Medicine
  • Pathophysiology
  • Exercise Physiology

JAFIB regularly invites minireviews from international authorities on topics of current interest. Some longer reviews, and book reviews are also published, usually by editors invitation. Editorials and letters to the editor on matters arising from published papers are also published at the editors discretion.

Broad coverage, editorial independence and consistent high standards will form the founding principles of JAFIB to serve as a communication medium for world class research in AF.


Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists